Losartan Potassium
Product Images NDC 53002-4624

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 53002-4624). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530024624)

FDA Label Image

Losartanaddress2 (Losartanaddress2)

FDA Label Image

Losartanfigure1 (Losartanfigure1)

FDA Label Image

Losartanfigure2 (Losartanfigure2)

Losartanfigure2 (Losartanfigure2)
This appears to be a graph or chart showing the percentage of patients with first-line or fatal strokes over a period of time, with annotations for study months. The text below the graph states that there is an "adjusted risk reduction" of 26%, with a p-value of 0.001. It is not clear what the context of this information is, as additional information or context may be necessary.*
FDA Label Image

Losartanfigure3 (Losartanfigure3)

FDA Label Image

Losartanfigure4 (Losartanfigure4)

FDA Label Image

Losartanstructure (Losartanstructure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.